NCT06109064 Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS Status RECRUITING Phase PHASE2
NCT06091267 PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06069024 Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide Status COMPLETED Phase N/A
NCT06050941 Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS Status NOT_YET_RECRUITING Phase PHASE2
NCT06047886 UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy Status RECRUITING Phase PHASE1
NCT06046313 Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS Status RECRUITING Phase PHASE2
NCT06045689 A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06021600 A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine Status TERMINATED Phase PHASE1
NCT06020833 A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06008405 Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy Status UNKNOWN Phase PHASE1
NCT06006949 Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS Status UNKNOWN Phase PHASE4
NCT06004765 Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS Status UNKNOWN Phase PHASE4
NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05991908 Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies Status RECRUITING Phase PHASE3
NCT05986240 Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML Status RECRUITING Phase PHASE1
NCT05970822 Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML Status RECRUITING Phase PHASE1
NCT05968963 Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase NA
NCT05949684 ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions Status ACTIVE_NOT_RECRUITING Phase PHASE3